QNRX vs. ASA

Last updated Jun 23, 2026

QNRX (Quoin Pharmaceuticals Ltd DRC) and ASA (ASA Gold and Precious Metals Limited) are both stocks. QNRX operates in Biotechnology (Healthcare), while ASA operates in Asset Management (Financial Services). Over the past 5 years, QNRX returned -85.89%/yr vs 21.94%/yr for ASA. At a 0.09 correlation, their price movements are largely independent.

Performance

QNRX vs. ASA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quoin Pharmaceuticals Ltd DRC (QNRX) and ASA Gold and Precious Metals Limited (ASA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, QNRX achieves a -69.44% return, which is significantly lower than ASA's -2.00% return.

QNRX

• 1D: -5.16%
• 1M: -7.55%
• YTD: -69.44%
• 6M: -67.93%
• 1Y: -49.31%
• 3Y*: -73.86%
• 5Y*: -85.89%
• 10Y*: —

ASA

• 1D: -1.30%
• 1M: -1.85%
• YTD: -2.00%
• 6M: -5.06%
• 1Y: 79.54%
• 3Y*: 58.58%
• 5Y*: 21.94%
• 10Y*: 15.72%

*Multi-year figures are annualized to reflect compound growth (CAGR)

QNRX vs. ASA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
QNRX Quoin Pharmaceuticals Ltd DRC	-69.44%	-36.64%	-86.73%	-71.21%	-93.76%	-78.94%	-2.70%	-78.86%	-70.00%	126.54%
ASA ASA Gold and Precious Metals Limited	-2.00%	195.60%	34.55%	5.38%	-32.06%	-3.48%	60.65%	44.35%	-16.18%	2.89%

Correlation

The correlation between QNRX and ASA is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.05
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.09
Correlation (All Time) Calculated using the full available price history since Jul 29, 2016	0.09

The correlation between QNRX and ASA shifts across timeframes, from -0.05 (1 year) to 0.09 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap QNRX : $12.48M ASA : $1.10B
EPS QNRX : -$13.39 ASA : $42.09
PB Ratio QNRX : 1.42 ASA : 1.00
Total Revenue (TTM) QNRX : $0.00 ASA : $137.30M
Gross Profit (TTM) QNRX : -$24.93K ASA : $3.98M
EBITDA (TTM) QNRX : -$17.28M ASA : $444.29M

Return for Risk

QNRX vs. ASA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QNRX

QNRX Risk / Return Rank: 34
QNRX Sharpe Ratio Rank: 31
QNRX Sortino Ratio Rank: 48
QNRX Omega Ratio Rank: 48
QNRX Calmar Ratio Rank: 20
QNRX Martin Ratio Rank: 22

ASA

ASA Risk / Return Rank: 79
ASA Sharpe Ratio Rank: 84
ASA Sortino Ratio Rank: 77
ASA Omega Ratio Rank: 77
ASA Calmar Ratio Rank: 78
ASA Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QNRX vs. ASA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quoin Pharmaceuticals Ltd DRC (QNRX) and ASA Gold and Precious Metals Limited (ASA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	QNRX	ASA	Difference
Sharpe ratio: Return per unit of total volatility	-0.26	1.62	-1.88
Sortino ratio: Return per unit of downside risk	0.72	2.00	-1.29
Omega ratio: Gain probability vs. loss probability	1.09	1.27	-0.18
Calmar ratio: Return relative to maximum drawdown	-0.61	2.25	-2.86
Martin ratio: Return relative to average drawdown	-0.98	5.96	-6.94

QNRX vs. ASA - Sharpe Ratio Comparison

The current QNRX Sharpe Ratio is -0.26, which is lower than the ASA Sharpe Ratio of 1.62. The chart below compares the historical Sharpe Ratios of QNRX and ASA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

QNRX vs. ASA - Drawdown Comparison

The maximum QNRX drawdown since its inception was -100.00%, which is greater than ASA's maximum drawdown of -80.36%. Use the drawdown chart below to compare losses from any high point for QNRX and ASA.

Drawdown Indicators

	QNRX	ASA	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-80.36%	-19.64%
Max Drawdown (1Y) Largest decline over 1 year	-81.17%	-35.50%	-45.67%
Max Drawdown (3Y) Largest decline over 3 years	-98.68%	-35.50%	-63.18%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-48.43%	-51.57%
Max Drawdown (10Y) Largest decline over 10 years	—	-51.66%	—
Current Drawdown Current decline from peak	-100.00%	-28.06%	-71.94%
Average Drawdown Average peak-to-trough decline	-81.53%	-42.52%	-39.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	50.56%	13.38%	+37.18%

Volatility

QNRX vs. ASA - Volatility Comparison

Quoin Pharmaceuticals Ltd DRC (QNRX) has a higher volatility of 23.57% compared to ASA Gold and Precious Metals Limited (ASA) at 17.84%. This indicates that QNRX's price experiences larger fluctuations and is considered to be riskier than ASA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QNRX	ASA	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.57%	17.84%	+5.73%
Volatility (6M) Calculated over the trailing 6-month period	60.92%	41.21%	+19.71%
Volatility (1Y) Calculated over the trailing 1-year period	190.41%	49.38%	+141.03%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	213.65%	35.56%	+178.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	172.31%	35.61%	+136.70%

Dividends

QNRX vs. ASA - Dividend Comparison

QNRX has not paid dividends to shareholders, while ASA's dividend yield for the trailing twelve months is around 0.12%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ASA ASA Gold and Precious Metals Limited	0.12%	0.10%	0.20%	0.13%	0.14%	0.09%	0.09%	0.15%	0.32%	0.35%	0.36%	0.56%
QNRX Quoin Pharmaceuticals Ltd DRC	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both QNRX and ASA in my portfolio?

QNRX and ASA have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, QNRX or ASA?

QNRX has higher volatility (23.57%) compared to ASA (17.84%). In terms of maximum drawdown, QNRX dropped -100.00% vs ASA's -80.36%.

Which has better risk-adjusted returns?

ASA currently has the higher Sharpe Ratio (1.62 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.